drugset / Trial / NCT01209234

Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

NCT01209234

RandomizedParallel-groupSingle-blindPrevention

Summary

This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.

Timeline

Start
2011-01
Primary completion
2019-01
Completion
2019-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule Topical
Comparator Mupirocin Small molecule Intranasal